1.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
by Fox, Caroline S, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1662-1673

2.
Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure
by Ortiz, Alberto, Prof
The Lancet (British edition), 2014, Vol.383 (9931), p.1831-1843

3.
Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
by Palmer, Suetonia C, PhD
The Lancet (British edition), 2015, Vol.385 (9982), p.2047-2056

4.
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis
by Mahmoodi, Bakhtawar K, MD
The Lancet (British edition), 2012, Vol.380 (9854), p.1649-1661

5.
Strategies for long-term preservation of kidney graft function
by Wekerle, Thomas, Prof
The Lancet (British edition), 2017, Vol.389 (10084), p.2152-2162

6.
All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan
by Wen, Chi Pang, MD
The Lancet (British edition), 2008, Vol.371 (9631), p.2173-2182

7.
Post-listing survival for highly sensitised patients on the UK kidney transplant waiting list: a matched cohort analysis
by Manook, Miriam, MBChB
The Lancet (British edition), 2017, Vol.389 (10070), p.727-734

8.
Infants with congenital nephrotic syndrome have comparable outcomes to infants with other renal diseases
by Dufek, Stephanie
Pediatric nephrology (Berlin, West), 2018-10-29, Vol.34 (4), p.649-655

9.
Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease
by Talbot, Andrew S
Heart (British Cardiac Society), 2015-02, Vol.101 (4), p.287-293

10.
Plasma concentrations of 8-hydroxy-2′-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes
by Sanchez, Manuel
Diabetologia, 2017-11-28, Vol.61 (4), p.977-984

11.
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
by Zoccali, Carmine
The Lancet (British edition), 2001-12-22, Vol.358 (9299), p.2113-2117

12.
Perioperative Complications and Mortality in Patients with Urothelial Carcinoma and End-Stage Renal Disease Undergoing One-Stage Complete Urinary Tract Extirpation
by Huang, Yun-Ching
Annals of surgical oncology, 2017-11-14, Vol.25 (2), p.573-581

13.
A Randomized Multicenter Open Label Blinded End Point Trial Comparing the Effects of Spironolactone to Chlorthalidone on Left Ventricular Mass in Patients with Early Stage Chronic...
by Hayer, MK, MB, ChB
The American heart journal, 2017, Vol.191, p.37-46

14.
Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease
by Fragoso, André
Journal of diabetes and its complications, 2015, Vol.29 (8), p.1098-1104

15.
Outcomes of renal replacement therapy in boys with prune belly syndrome: findings from the ESPN/ERA-EDTA Registry
by Yalcinkaya, Fatos
Pediatric nephrology (Berlin, West), 2018, Vol.33 (1), p.117-124

16.
Outcomes of infants receiving chronic peritoneal dialysis: an analysis of the USRDS registry
by Sanderson, Keia R
Pediatric nephrology (Berlin, West), 2018-08-23, Vol.34 (1), p.155-162

17.
The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes
by Costacou, Tina
Journal of diabetes and its complications, 2016, Vol.30 (2), p.221-226

18.
Hemodialysis vascular access and subsequent transplantation: a report from the ESPN/ERA-EDTA Registry
by Boehm, Michael
Pediatric nephrology (Berlin, West), 2019, Vol.34 (4), p.713-721

19.
Colostomy in children on chronic peritoneal dialysis
by Chan, Eugene Y. H
Pediatric nephrology (Berlin, West), 2019-10-30, Vol.35 (1), p.119-126

20.
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes
by Afkarian, Maryam
Journal of diabetes and its complications, 2015, Vol.29 (8), p.1024-1031
